london euretina
retina race

Dome-shaped macula in myopic eyes: 12 month follow-up

Session Details

Session Title: Imaging IV

Session Date/Time: Sunday 20/09/2015 | 11:00-13:00

Paper Time: 12:44

Venue: Thalie.

First Author: : D.Lorenzo Parra SPAIN

Co Author(s): :    E. Millan   N. Choudhry   L. Arias   I. Flores   M. Estefania Cobos   P. Josep Maria Caminal

Abstract Details

PURPOSE:To investigate the clinical course of dome-shaped macula (DSM) in myopic eyes and evaluate treatment responses for serous retinal detachment (SRD) as a related complication.

Setting:

Retrospective, observational case series with a minimal of 12-month follow-up (mean: 23 months).

Methods:

We analyzed data from DSM eyes of patients who underwent complete ophthalmic evaluation due to decreased vision. DSM was defined as a convexity of the retina-choroidal macular complex on horizontal, vertical or both scans by spectral-domain optical coherence tomography (SD-OCT) images. Fluorescein angiography and/or indocyanine green angiography were only performed in cases with SRD, in order to rule out choroidal neovascularization.

Results:

We studied 56 DSM eyes in 36 patients with a mean age of 56.9 ± 13.1 years (unilateral in 16 patients, 44%; bilateral in 20 patients, 55.6%). The mean spherical equivalent was -9.1 ± 6.0 diopters. SD-OCT scan patterns detected the bulge anatomy as follow: 37 eyes (66.1%) in vertical scans, 14 eyes (25%) in horizontal scans and 5 eyes (8.9%) in both scans. The mean initial best-corrected visual acuity (BCVA) was 0.48 (logMAR); at the last visit, it was 0.52 (p≥ 0.1). Baseline SRD was exhibited in 29 eyes (51.8%). BCVA was not significantly lower in eyes with SRD than in eyes without SRD (p≥ 0.05). A total of 19 eyes with SRD were treated (8 eyes with low-fluence photodynamic therapy, 7 eyes with bevacizumab, and 4 eyes with ranibizumab), and 10 eyes with SRD did not receive any treatment. Statistically significant results were not found on improvement of BCVA (p≥ 0.1), and on resolution of SRF (p≥ 0.1), in the comparison between the treatment and non-treatment groups.

Conclusions:

DSM is a condition related to highly myopic eyes that is often associated with chronic SRD, for which no effective treatment can be applied. In these cases, SRD cannot be considered as a significant cause of visual impairment.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy